To celebrate World Asthma Day 2021 we launch a new review comparing combination fast-acting beta-agonist and steroid inhaler as required with either regular inhaled steroids or fast-acting beta-agonists as required alone in adults or children with mild asthma. Read more about it in this interview with one of the lead authors, Tim Hinks, based at the University of Oxford.

Link to the full review

Link to the interview